Research&Innovation
Home > Research&Innovation > R&D Profile
 

R&D and continuous Technology Innovation is the driving force for sustainable development. Acebright has established one national key laboratory (the National Key Laboratory of Antibody Drugs Research), one national enterprise technology center (the Shanghai Acebright Pharmaceuticals Group Technology Center), one provincial enterprise technology center (the Chifeng Pharma Technology Center) and a postdoctoral research station (the Shanghai Desano Pharmaceutical Postdoctoral Research Station).

We have undertaken a series of national key research and development projects (such as new drugs research and development projects of the “863”and“125” plans)in our R&D centers. We have completed or are conducting 15 national R&D projects and about 50 provincial R&D programs.

 
All Rights Reserved:Shanghai Acebright Pharmaceuticals Group Co., Ltd. 2018
ICP:NO.12044760  
幸运快3 幸运快3官网 幸运快三官网 幸运快三计划 幸运快三 幸运快三计划 幸运快3技巧 幸运快三走势图 幸运快三 幸运快3开奖结果走势图